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Between August 1985 and March 2004， we performed transurethral resection of the prostate 
(TURP) in 18 patients with benign prostatic hyperplasia (BPH) whose prostatic volume was larger 
than 100 ml. We divided the patients into two groups. Group A consisted ofa total of 14 cases: 10 
cases whose mean prostate volume was 114 ml (100 to 137 ml) and 4 cases whose prostate volume was 
not measured before TURP but whose mean resected prostatic tissue weight was 113 g (105 to 118 g). 
Group B consisted of 4 cases whose mean prostate volume was 110 ml (101 to 133 ml). Patients in 
group B underwent interstitiallaser coagulation ofthe prostate (ILCP) followed by oral chlormadinone 
acetate (CMA) therapy (50 mg/day); TURP was performed 6 months later， once the prostate volume 
had shrunk to an average of 76 ml (66 to 91 ml). Mean resected weights and operation times were: 
group A， 93.1 g， 66.3 min; group B， 60.5 g， 55.7 min. There were 12 blood transfusion cases (85.7% ; 
intraoperative) in group A， and 1 (25.0%; POD 1) in group B. Accordingly， this preoperative 
treatment was considered a safer method of TURP for BPH 100 ml or more. There were no cases of 
TURP syndrome or death in either group. 
(Hinyokika Kiyo 51・159-164，2005) 



































8.2 (5-14) ml/sec，残尿量は平均 142(50-298) ml 
であった. 4例で測定した血中 PSA値は平均 5.6
(3.8-7.1) ng/mlであり， PSA density は平均0.06
(0.04-0.07)であった.
B群:前立腺容積が 100ml以上で， ILCP施行後
に， t克アンドロゲン剤である CMA50mgl 日を m~用
し， 6カ月後に TURPを行った4症例.年齢は平均
75.2 (78-82)歳であった.最大尿流率は平均 11.2
(10.8-12) ml/sec，残尿量は平均 121(87-18I)ml 
であった.血中 PSA値は平均 8.1(5.5-12.6) ngl 
ml， PSA density は平均0.07(0.05-0.09)であっ

































フェニレフリン 0.5mgの混合液 2mlである. Igle-

































量は平均 840(400-1，800) mlであった. 100g未満
の症例では， 7例 (77.8%) に同様の理由で症例
あたり 4DOmlを輸血した.A群全体では，輸血頻度




Table 1. Operative data and complications of 
TURP for BPH with a prostatic 
volume of 100 ml or more: Compari-
son between large (100 g or more) 
and smaJl (under 100 g) resected 
prostatic tissue weight 
Weight of prostatic 
tlssue resected 
100g> 100g三五
Number ofpatients 9 5 
Age (yr)a 71.1 (55-88) 79.8 (76-85) 
W(g) 4ghtof resectEd t国 ue 85.2 (77-96) 112.8 (100-118) 
Operation time (min)a 62.8 (50-74) 75.0 (60-107) 
Postop. catheter (day)a 2.8 (2-3) 3.8 (3-7) 
Blood transfusionb 7 (7.8) 5 (100) 
TURP syndromeb 0(0) 0(0) 
Capsular perforationb 0(0) 0(0) 
U rethral strictureb 0(0) 1 (20) 
Deathb 0(0) 0(0) 
a: Mean (range)， b:N umber of patients (percentage) 
前で平均 110(101~133) mlであったが，治療 1カ月
後には平均 102.5(91~125) ml，治療3カ月後には
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Fig. 1. Change of prostatic volume a仇erinter-
stitial laser coagulation of the prostate 
(ILCP) plus chlormadinone acetate 
(CMA) therapy. 
Table 2. Operative data and complications in 
4 patients recieving TURP at 6 
months a氏erinterstitial laser coagu-
lation of the prostate plus chlor-
madinone acetate therapy 
Age (yr)' 
Weight of resected tissue (g)" 
Operation time (min)a 















a: Mean (range)， b:Number of patients (percentage) 
を行なったが，手術時間は全例60分以下であった
(Table 2). 血中ヘモグロビン値は，術前平均 12.5











確ではない Mebustら8)は 前立腺容積 100ml以
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Table 3. Operative data and complications of various operations for large BPH (resected prostatic tissue 
weight of 80 g or more， or prostatic volume of 100 ml or more) 
Au伽 n M321g)a OPE12ivimE ca出12:布切 Truns
Transurethral Resection of the prostate 
Nakajima et al. (1988)11) I 133 (105-180) 104 (65-140) 7 (5-17) I (100) 0(0) 0(0) 
Agarwal et al. (1993) 12) 47 101 (80-170) 74 (一) 40 (85) 13 (28) 3 (6) 
Uchida et al. (1993) 6) 30 101:孟 144 (75-240) 5 (5-13) 28 (93.3) 0(0) 0(0) 
Present study 14 93.1 (77-118) 66.3 (50-107) 3.6 (2-7) 12 (85.7) 0(0) 0(0) 
Open Prostatcctomy 
Yazaki et al. (1982) 13) 5 11.8 (102-136) 133.4 (110-164) 
Moody et al. (2001) 14) 10 106 (24-209) 173 (-) 3 (30) 0(0) 
Kuntz et al. (2002)問 60 96.4 (45-220) 90.6 (55-135) 8.1 (7-12) 8 (13.3) 0(0) 
Transurethral Holmium Laser Enucleation 
Moody et al. (2001) 14) 10 151 (97-227) 197 (一) Within 23 hrs 0(0) 0(0) 0(0) (8 cases) 
Kuntz et al. (2002) 15) 60 83.9 (52-200) 135.9 (80-216) 1.3 (1同6) 0(0) 0(0) 0(0) 














































小と尿道閉塞を減少させる治療法である 16) ILCP 
による前立腺容積の縮小率は8.3-41.6%と報告され
ている 16) 同様に. CMAも前立腺の縮小効果を有
するが，主として前立腺上皮細胞の退行性変化や萎縮




















































前立腺容積 100m!以上の BPHに対する TURP
においては輸血の頻度が高いため，施行にあたっては
輸血の準備や術中の心循環器系の管理が必要である.
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